ChiCTR-DDD-16007735Active, not recruiting诊断试验新技术临床试验
评估 68Ga-NODAGA-R01 PET/CT 在胰腺癌、肺癌、结直肠癌、胃癌、宫颈癌、卵巢癌、脑神经胶质瘤的应用价值
自筹1 site in 1 countryStarted: January 11, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 诊断试验新技术临床试验
- Status
- Active, not recruiting
- Sponsor
- Locations
- 1
- Primary Endpoint
- 最大标准摄取值
Study Overview
Brief Summary
评价 68Ga-NODAGA-R01 PET/CT 显像在临床肿瘤患者的诊断价值和预后应用价值。
Study Design
- Study Type
- 诊断试验
- Primary Purpose
- 诊断试验诊断准确性
Eligibility Criteria
- Ages
- 20 to 70 (—)
- Sex
- All
Inclusion Criteria
- •1.年龄在 20-70 岁之间；
- •2.可行手术或活检得到最终病理结果；
- •3.知情同意并能够接受随访
Exclusion Criteria
- •排除妊娠期和哺乳期女性患者；
- •排除因病情较重难以接受进一步诊治患者;
Outcomes
Primary Outcomes
最大标准摄取值
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
68Ga-DOTA-NT PET/CT 显像在肿瘤诊断中的应用肿瘤ChiCTR-DDD-16009064自筹
Unknown
Not Applicable
68GA-NOTA-E(PEG4-TMVP1)2 的 PET/CT 显像对宫颈癌、卵巢癌、乳腺癌和肺癌的诊断应用ChiCTR-DOD-17012458北京协和医院
Unknown
Not Applicable
68Ga-DOTA-TMVP1 在肿瘤显像诊断中的应用ChiCTR-DOD-15006474北京协和医院
Unknown
Not Applicable
68Ga/18F-PSMA 在肿瘤的 PET 显像研究恶性肿瘤ChiCTR2100050105北京大学第一医院自筹
Recruiting
Phase 2
Role of [68Ga]Ga-FAPI PET/CT in oncological patients with doubtful or inconclusive findings at [18F]F-FDG PET/CT2024-518765-96-00Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico200